Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for IMTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -9.277M
March 31, 2026 -32.86M
December 31, 2025 -34.76M
September 30, 2025 147.24M
June 30, 2025 76.61M
March 31, 2025 49.26M
December 31, 2024 -47.22M
September 30, 2024 69.84M
June 30, 2024 77.29M
March 31, 2024 -262.46M
December 31, 2023 65.37M
September 30, 2023 -76.76M
June 30, 2023 -18.38M
March 31, 2023 -3.990M
December 31, 2022
Date Value
September 30, 2022
June 30, 2022 -58.19M
March 31, 2022 6.547M
December 31, 2021 -2.422M
September 30, 2021 23.41M
June 30, 2021 -15.50M
March 31, 2021 3.082M
December 31, 2020 -0.8382M
September 30, 2020 -13.15M
June 30, 2020 -2.381M
March 31, 2020 -2.630M
December 31, 2019 -15.41M
September 30, 2019 14.30M
June 30, 2019 -0.8736M
March 31, 2019 -0.3781M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
MediGene AG --
InflaRx NV 14.90M
BioNTech SE -118.82M
Moderna, Inc. 329.00M
Intellia Therapeutics, Inc. -141.57M